SI1708790T1 - Uporaba pipamerona in d receptorskega antagonista kot serotonin dopamin antagonista za zdravljenjepsihičnih nepravilnosti - Google Patents
Uporaba pipamerona in d receptorskega antagonista kot serotonin dopamin antagonista za zdravljenjepsihičnih nepravilnostiInfo
- Publication number
- SI1708790T1 SI1708790T1 SI200431439T SI200431439T SI1708790T1 SI 1708790 T1 SI1708790 T1 SI 1708790T1 SI 200431439 T SI200431439 T SI 200431439T SI 200431439 T SI200431439 T SI 200431439T SI 1708790 T1 SI1708790 T1 SI 1708790T1
- Authority
- SI
- Slovenia
- Prior art keywords
- antagonist
- dopamin
- pipamperone
- serotonin
- treatment
- Prior art date
Links
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 title 2
- 208000028017 Psychotic disease Diseases 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 title 1
- 229960003638 dopamine Drugs 0.000 title 1
- AXKPFOAXAHJUAG-UHFFFAOYSA-N pipamperone Chemical compound C1CC(C(=O)N)(N2CCCCC2)CCN1CCCC(=O)C1=CC=C(F)C=C1 AXKPFOAXAHJUAG-UHFFFAOYSA-N 0.000 title 1
- 229960002776 pipamperone Drugs 0.000 title 1
- 239000002464 receptor antagonist Substances 0.000 title 1
- 229940044551 receptor antagonist Drugs 0.000 title 1
- 229940076279 serotonin Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (14)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03447279A EP1547650A1 (en) | 2003-12-02 | 2003-12-02 | Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists |
| CA2451798A CA2451798C (en) | 2003-12-02 | 2003-12-02 | Use of d4 and 5-ht2a antagonists, inverse agonists or partial agonists |
| US10/725,965 US7884096B2 (en) | 2003-12-02 | 2003-12-02 | Method of treating mental disorders using of D4 and 5-HT2A antagonists, inverse agonists or partial agonists |
| EP04447001 | 2004-01-05 | ||
| US10/752,423 US7855195B2 (en) | 2003-12-02 | 2004-01-06 | Method of treating mental disorders using D4 and 5-HT2A antagonists, inverse agonists or partial agonists |
| EP04447066A EP1576985A1 (en) | 2004-03-18 | 2004-03-18 | Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists |
| CA 2461248 CA2461248C (en) | 2003-12-02 | 2004-03-18 | Use of d4 and 5-ht2a antagonists, inverse agonists or partial agonists |
| US10/803,793 US20050119249A1 (en) | 2003-12-02 | 2004-03-18 | Method of treating neurodegenerative diseases using D4 and 5-HT2A antagonists, inverse agonists or partial agonists |
| EP04025035A EP1541197B8 (en) | 2003-12-02 | 2004-10-21 | Use of pipamperone and an SNDRI, SNRI or SSRI for the treatment of mood or anxiety disorders |
| JP2004349085A JP4571485B2 (ja) | 2003-12-02 | 2004-11-04 | Ｄ４および５−ｈｔ２ａアンタゴニスト、逆アゴニストまたは部分アゴニストの使用 |
| US10/984,683 US20050203130A1 (en) | 2003-12-02 | 2004-11-09 | Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists |
| CA 2487529 CA2487529A1 (en) | 2003-12-02 | 2004-11-15 | Use of d4 and 5-ht2a antagonists, inverse agonists or partial agonists |
| EP04801138A EP1708790B1 (en) | 2003-12-02 | 2004-12-02 | Use of pipamperone and a d2-receptor antagonist or a serotonin/dopamin antagonist for the treatment of psychotic disorders |
| PCT/BE2004/000172 WO2005053796A1 (en) | 2003-12-02 | 2004-12-02 | Use of d4 and 5-ht2a antagonists, inverse agonists or partial agonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI1708790T1 true SI1708790T1 (sl) | 2010-09-30 |
Family
ID=42134278
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200431439T SI1708790T1 (sl) | 2003-12-02 | 2004-12-02 | Uporaba pipamerona in d receptorskega antagonista kot serotonin dopamin antagonista za zdravljenjepsihičnih nepravilnosti |
Country Status (8)
| Country | Link |
|---|---|
| AT (1) | ATE464901T1 (sl) |
| DE (1) | DE602004026781D1 (sl) |
| DK (1) | DK1708790T3 (sl) |
| ES (1) | ES2343962T3 (sl) |
| HR (1) | HRP20100376T1 (sl) |
| PT (1) | PT1708790E (sl) |
| RS (1) | RS51331B (sl) |
| SI (1) | SI1708790T1 (sl) |
-
2004
- 2004-12-02 RS RSP-2010/0323A patent/RS51331B/en unknown
- 2004-12-02 AT AT04801138T patent/ATE464901T1/de active
- 2004-12-02 ES ES04801138T patent/ES2343962T3/es not_active Expired - Lifetime
- 2004-12-02 DE DE602004026781T patent/DE602004026781D1/de not_active Expired - Lifetime
- 2004-12-02 PT PT04801138T patent/PT1708790E/pt unknown
- 2004-12-02 DK DK04801138.1T patent/DK1708790T3/da active
- 2004-12-02 SI SI200431439T patent/SI1708790T1/sl unknown
-
2010
- 2010-07-06 HR HR20100376T patent/HRP20100376T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE464901T1 (de) | 2010-05-15 |
| DE602004026781D1 (de) | 2010-06-02 |
| DK1708790T3 (da) | 2010-06-21 |
| HRP20100376T1 (hr) | 2010-08-31 |
| PT1708790E (pt) | 2010-07-09 |
| RS51331B (en) | 2011-02-28 |
| ES2343962T3 (es) | 2010-08-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL1708790T3 (pl) | Zastosowanie pipamperonu oraz antagonisty receptora D2 lub antagonisty receptora serotoniny/dopaminy do leczenia zaburzeń psychotycznych | |
| AU2003249983A8 (en) | Piperidines useful for the treatment of central nervous system disorders | |
| HK1079203A1 (en) | Substituted amine derivatives and methods of use in the treatment of angiogenesis related disorders | |
| IL176248A0 (en) | N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof | |
| IL166058A0 (en) | Novel thiophenylglycoside derivatives methods for production thereof medicaments comprising said compounds and use thereof | |
| ZA200509542B (en) | Combination of an NDMA receptor antagonist and a selective serotonin reuptake inhibitor for the treatment of depression and other mood disorders | |
| GB0215853D0 (en) | Summarisation representation apparatus | |
| PL370548A1 (en) | Piperazine derivatives with ccr1 receptor antagonist activity | |
| IL157328A0 (en) | Treatment involving dkk-1 or antagonists thereof | |
| EP1638565A4 (en) | SUBSTITUTED PIPERIDINE COMPOUNDS AND METHOD OF USE THEREOF | |
| IL157145A0 (en) | Use of dc23 antagonists for the treatment of neoplastic disorders | |
| PT1487828E (pt) | Derivados de morfolinil-ureia para utilização no tratamento de doenças inflamatórias | |
| AU2003275056A8 (en) | Novel lapacho compounds and methods of use thereof | |
| AU2003277215A8 (en) | Novel neurokinin antagonists and methods of use thereof | |
| AU2003210730A8 (en) | Azabicyclo-substituted benzoylamides and thioamides for treatment of cns-related disorders | |
| HUP0301551A3 (en) | New use of 5ht3 and neuronal nicotinicreceptor antagonist 1-amino-alkycyclohexanes | |
| PL370449A1 (en) | Therapeutic acridone and acridine compounds | |
| IL158703A0 (en) | 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders | |
| HK1087924A1 (en) | Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists | |
| GB0207410D0 (en) | Compounds and their therapeutic use | |
| IL158632A0 (en) | 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders | |
| SI1708790T1 (sl) | Uporaba pipamerona in d receptorskega antagonista kot serotonin dopamin antagonista za zdravljenjepsihičnih nepravilnosti | |
| PT1503746E (pt) | Utilização farmacêutica de inibidores da cox-2 em perturbações oculares mediadas pela angiogénese | |
| IL161521A0 (en) | N-formyl derivatives of paroxetine | |
| GB0211083D0 (en) | Height adjustable wheelchair |